Home Cart 0 Sign in  
X

[ CAS No. 92197-36-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 92197-36-9
Chemical Structure| 92197-36-9
Chemical Structure| 92197-36-9
Structure of 92197-36-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 92197-36-9 ]

Related Doc. of [ 92197-36-9 ]

Alternatived Products of [ 92197-36-9 ]

Product Details of [ 92197-36-9 ]

CAS No. :92197-36-9 MDL No. :MFCD20921479
Formula : C13H19NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :YBYAVGXEXYQIPB-UHFFFAOYSA-N
M.W : 221.30 Pubchem ID :14025336
Synonyms :

Calculated chemistry of [ 92197-36-9 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.54
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 67.31
TPSA : 43.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.97
Log Po/w (XLOGP3) : 0.76
Log Po/w (WLOGP) : 0.47
Log Po/w (MLOGP) : 1.14
Log Po/w (SILICOS-IT) : 1.81
Consensus Log Po/w : 1.23

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.77
Solubility : 3.76 mg/ml ; 0.017 mol/l
Class : Very soluble
Log S (Ali) : -1.26
Solubility : 12.2 mg/ml ; 0.0553 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.78
Solubility : 0.37 mg/ml ; 0.00167 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.88

Safety of [ 92197-36-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 92197-36-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 92197-36-9 ]
  • Downstream synthetic route of [ 92197-36-9 ]

[ 92197-36-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 109105-86-4 ]
  • [ 92197-36-9 ]
YieldReaction ConditionsOperation in experiment
82%
Stage #1: With potassium osmate(VI); methanesulfonamide; water; potassium carbonate; potassium hexacyanoferrate(III) In <i>tert</i>-butyl alcohol at 0 - 20℃; for 22 h;
Stage #2: With sodium sulfite In <i>tert</i>-butyl alcohol at 20℃; for 1 h;
A3a) 1-benzyl-4-hydroxymethyl-piperidin-4-ol A solution of 200 g AD-Mix-Alpha (Messrs Aldrich, Item no. 39,275-8) in 500 mL water and 300 mL tert-butanol was stirred for 20 min at RT, cooled to 0° C., combined with 13.7 g (144 mmol) methanesulphonic acid amide and 27.0 g (144 mmol) of 1-benzyl-4-methylene-piperidine and, after removal of the cooling bath, stirred for 22 h at RT. 59 g Na2SO3 were added to the reaction mixture and it was stirred for 1 h at RT. 2 L EtOAc and 500 mL saturated NaHCO3 solution were added, the organic phase was separated off and dried over Na2SO4 . After the desiccant and solvent had been eliminated the residue was dissolved in 150 mL EtOAc and filtered through Alox. The filtrate was discarded and the product was eluted from the Alox with 1 L MeOH. After the solvent had been eliminated the product was reacted further without purification. Yield: 26.0 g (82percent of theory) ESI-MS: (M+H)+=222 retention time (HPLC): 1.4 min (method B)
Reference: [1] Patent: US2005/256099, 2005, A1, . Location in patent: Page/Page column 159
[2] Patent: WO2005/103037, 2005, A2, . Location in patent: Page/Page column 170-171
  • 2
  • [ 19867-34-6 ]
  • [ 92197-36-9 ]
YieldReaction ConditionsOperation in experiment
77% With sulfuric acid In water at 20℃; for 20 h; A solution of the epoxide (1.33 g, 6.54 mmol) in aqueous 0.2 M sulfuric acid (82 mL) was stirred at room temperature for 20 hours. The solution was cooled to 0 °C, and sodium carbonate was added until the pH of the aqueous mixture reached 12. The mixture was then diluted with water (20 ML), and extracted with ethyl acetate (3x 200 ML). The combined organic layers were dried (magnesium sulfate), filtered, and concentrated under reduced pressure. The resulting white solid was purified via flash chromatography eluting with a gradient of dichloromethane : methanol (5: 1 to 1: 1) to deliver the title compound as a waxy solid (1.12 g, 77percent). MS (APCI) (M+1/Z) 221.1.
58% at 20℃; A mixture of Compound 2 (30.5 g, 150 mmol) in H2S04 (37.5 g, 380 mmol, 0.2 M) was stirred at rt overnight. The mixture was neutralized with Na2C03 to pHIO and extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2S04 and concentrated to give the desired product (20.0 g, 58percent). 1H NMR (400 MHz, CD3OD): δ ppm: 7.29-7.22(m, 5H), 3.50(s, 2H), 3.44(s, 2H), 3.31-3.27 (m, 2H), 2.61-2.58(m, 2H), 2.41-2.36(m, 2H), 1.69-1.64(m, 2H), 1.51-1.49(m, 2H).
Reference: [1] Patent: WO2005/26145, 2005, A2, . Location in patent: Page/Page column 85; 106; 107
[2] Patent: WO2013/96744, 2013, A1, . Location in patent: Page/Page column 194
[3] Patent: EP1568688, 2005, A1, . Location in patent: Page/Page column 37
[4] Patent: EP1391452, 2004, A1, . Location in patent: Page 24
  • 3
  • [ 60437-30-1 ]
  • [ 92197-36-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 2, p. 486 - 491
  • 4
  • [ 3612-20-2 ]
  • [ 92197-36-9 ]
Reference: [1] Patent: WO2013/96744, 2013, A1,
  • 5
  • [ 92197-36-9 ]
  • [ 240401-25-6 ]
Reference: [1] Patent: US2011/288065, 2011, A1, . Location in patent: Page/Page column 44
[2] Patent: JP5668756, 2015, B2, . Location in patent: Paragraph 0124
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 92197-36-9 ]

Aryls

Chemical Structure| 67686-01-5

[ 67686-01-5 ]

(1-Benzylpiperidin-4-yl)methanol

Similarity: 0.88

Chemical Structure| 384338-20-9

[ 384338-20-9 ]

1-Benzyl-4-methylpiperidin-3-ol

Similarity: 0.87

Chemical Structure| 4727-72-4

[ 4727-72-4 ]

1-Benzylpiperidin-4-ol

Similarity: 0.86

Chemical Structure| N/A

[ N/A ]

((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol

Similarity: 0.83

Chemical Structure| 5731-17-9

[ 5731-17-9 ]

1-(Phenylmethyl)-3-pyrrolidinemethanol

Similarity: 0.82

Alcohols

Chemical Structure| 67686-01-5

[ 67686-01-5 ]

(1-Benzylpiperidin-4-yl)methanol

Similarity: 0.88

Chemical Structure| 384338-20-9

[ 384338-20-9 ]

1-Benzyl-4-methylpiperidin-3-ol

Similarity: 0.87

Chemical Structure| 4727-72-4

[ 4727-72-4 ]

1-Benzylpiperidin-4-ol

Similarity: 0.86

Chemical Structure| N/A

[ N/A ]

((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol

Similarity: 0.83

Chemical Structure| 5731-17-9

[ 5731-17-9 ]

1-(Phenylmethyl)-3-pyrrolidinemethanol

Similarity: 0.82

Related Parent Nucleus of
[ 92197-36-9 ]

Aliphatic Heterocycles

Chemical Structure| 67686-01-5

[ 67686-01-5 ]

(1-Benzylpiperidin-4-yl)methanol

Similarity: 0.88

Chemical Structure| 384338-20-9

[ 384338-20-9 ]

1-Benzyl-4-methylpiperidin-3-ol

Similarity: 0.87

Chemical Structure| N/A

[ N/A ]

((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol

Similarity: 0.83

Chemical Structure| 1262988-77-1

[ 1262988-77-1 ]

1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride

Similarity: 0.80

Chemical Structure| 90365-74-5

[ 90365-74-5 ]

(3S,4S)-1-Benzyl-3,4-pyrrolidindiol

Similarity: 0.77

Piperidines

Chemical Structure| 67686-01-5

[ 67686-01-5 ]

(1-Benzylpiperidin-4-yl)methanol

Similarity: 0.88

Chemical Structure| 384338-20-9

[ 384338-20-9 ]

1-Benzyl-4-methylpiperidin-3-ol

Similarity: 0.87

Chemical Structure| 4727-72-4

[ 4727-72-4 ]

1-Benzylpiperidin-4-ol

Similarity: 0.86

Chemical Structure| 14813-01-5

[ 14813-01-5 ]

1-Benzylpiperidin-3-ol

Similarity: 0.80

Chemical Structure| 1262988-77-1

[ 1262988-77-1 ]

1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride

Similarity: 0.80